Key result
Abdominal aortic aneurysm linked to ~52% higher odds of cancer vs. matched controls.
Why the study?
Prior studies linking abdominal aortic aneurysms and cancers were limited in power, leaving it unclear whether their coexistence is a collision, association, or causation.
Is abdominal aortic aneurysm associated with an increased prevalence and risk of malignant cancer compared to matched controls with and without heart failure in adults aged >50 years?
Cohort (n=2,469)
Yes
Is abdominal aortic aneurysm associated with an increased prevalence and risk of malignant cancer compared to matched controls with and without heart failure in adults aged >50 years?
Patients with abdominal aortic aneurysm have a significantly elevated prevalence of concomitant cancer (45.2%) and higher cancer-related mortality compared to matched controls, supporting the need for targeted cancer and aneurysm screening strategies.
Answers are grounded in this paper and cite their sources.
May warrant vigilance for cancer in AAA patients; leaves open causality and optimal screening strategies.
Cancers and abdominal aortic aneurysms (AAA) cause substantial morbidity and mortality and commonly develop in old age. It has been previously reported that AAA patients have a high prevalence of cancers, which has raised the question of whether this is a simple collision, association or causation. Clinical trials or observational studies with sufficient power to prove this association between them were limited because of the relatively low frequency and slow disease process of both diseases. We aimed to determine whether there is a significant association between AAA and cancers using nationwide data. The patients aged > 50 years and diagnosed with AAA between 2002 and 2015, patients with heart failure (HF) and controls without an AAA or HF matched by age, sex and cardiovascular risk factors were enrolled from the national sample cohort from the National Health Insurance claims database of South Korea. The primary outcome was the prevalence rate of cancers in the participants with and without an AAA. The secondary outcome was cancer-related survival and cancer risk. Overall, 823 AAA patients (mean (standard deviation) age, 71.8 (9.4) years; 552 (67.1%) men) and matching 823 HF patients and 823 controls were identified. The prevalence of cancers was 45.2% (372/823), 41.7% (343/823) and 35.7% (294/823) in the AAA, HF and control groups, respectively; it was significantly higher in the AAA group than in the control group (p < 0.001). The risk of developing cancer was higher in the AAA patients than in the controls (adjusted odds ratio (OR), 1.52 (95% confidence interval [CI], 1.24–1.86), p < 0.001) and in the HF patients (adjusted OR, 1.37 (1.24–1.86), p = 0.006). The cancer-related death rate was 2.64 times higher (95% CI, 2.22–3.13; p < 0.001) for the AAA patients and 1.63 times higher (95% CI, 1.37–1.92; p < 0.001) for the HF patients than for the controls. The most common causes of death in the AAA patients were cancer and cardiovascular disease. There was a significantly increased risk of cancer in the AAA than in the HF and control groups. Therefore, appropriate screening algorithms might be necessary for earlier detection of both diseases to improve long-term survival.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) conducted a cohort in Abdominal aortic aneurysm and concomitant cancer (n=2,469). Abdominal aortic aneurysm (AAA) diagnosis vs. Matched controls without AAA or heart failure (and a matched heart failure group) was evaluated on Prevalence and risk of developing any malignant cancer (ICD-10 codes C00-97) (OR 1.52, 95% CI 1.24-1.86, p=<0.001). Abdominal aortic aneurysm was associated with a higher prevalence of cancer compared to matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: